Inflammation of the synovium surrounding a tendon, also known as tenosynovitis, is a common MR imaging finding in early rheumatoid arthritis (RA) and including its presence in a newly developed scoring criterion may offer an improved approach for early identification of RA, according to a study published June 21 online in Radiology.

The latest studies related to advanced visualization show how new technology is bringing home the ideal trifecta of reduced costs, improved efficiency and better quality of care and outcomes.

The Medical Device User Fee and Modernization Act (MDUFMA) is a go. Three weeks after the Senate and House produced a reconciled version of the bill, President Barack Obama signed it into law July 9 as part of the Food and Drug Safety and Innovation Act.

Philips Healthcare and Therapeutic Monitoring Systems are collaborating to integrate clinical decision support (CDS) software, being developed by Ottawa-based Therapeutic Monitoring, into Philips' cardiopulmonary monitors.

Novation, a U.S. group purchasing organization serving the healthcare industry, has awarded Triad Isotopes with a contract to become one of its radiopharmaceutical suppliers.

Utilization of pediatric coronary CT angiography (CCTA) has lagged behind adoption of adult CCTA, but recent research may fuel a change. Dual-source CCTA with beta-blockers delivered diagnostic quality images at a median effective age-adjusted radiation dose of 0.97 mSv, according to a study published in the July issue of Journal of Cardiovascular Computed Tomography.

The modern electronic medical record (EMR) is a gold mine of data for the health care executive, but that gold too often goes un-mined. At Illinois-based NorthShore University HealthSystem, accessing the mother lode of usable information begins with a database of about two million patients and 100 million transactions.

Source: Radiology 2012;264:225-233MR imaging utilizing ultrasmall superparamagnetic iron oxide (USPIO) particles in combination with the current standard of a gadolinium-based contrast agent enabled detection of over 50 percent more multiple sclerosis (MS) lesions than imaging with gadolinium alone, according to research published in the July issue of Radiology.